Growth stocks have been leading the market for years. They tend to outperform the S&P 500 and other major indices. Over the past few decades, growth has consistently provided better returns than value stocks and, as a result, they are widely favored by investors.
Growth costs money, so growth stocks demand some of the highest PE premiums on the stock market. However, some growth plays are still cheap enough for the average retail investor to start to afford.
Traders who want to take a deeper dive into growth stocks should consider signing up for Dork Alerts. If you sign up now, you’ll get the Dork’s 2020 Growth Stock Guide as our free gift. There’s no cost or obligation, so sign up for free today
Best Growth Stocks
Here are the best growth stocks you can buy for cheap right now.
Arrowhead Pharmaceuticals Inc. (ARWR)
Arrowhead is a Pasadena-based pharmaceutical company whose products act via RNA interference mechanisms. Arrowhead’s stock is one of the best performers of the year, as it is up by 276% since the start of the year.
The company’s stock price remains affordable despite massive gains recorded so far in 2019. Arrowhead recently announced a planned management transition. The changes in management could lead to changes in the company’s activities. This could lead to further growth for the pharmaceutical company over the coming weeks and months.
Teradyne, Inc. (TER)
Massachusetts-based developer and supplier of automatic test equipment have had a phenomenal 2019 to date. The stock is up by 96% since the start of the year and could end 2019 even higher than its current price.
Teradyne would pay a cash dividend of $0.09 per share on December 20 to shareholders who hold the stock at the end of November 27’s trading session. Teradyne’s stock has outperformed the S&P500 so far this year and it could surge even higher before the year closes out.
Brookfield Infrastructure Partners L.P. (BIP)
Another cheap growth stock is Brookfield Infrastructure Partners. The Canadian company acquires and manages infrastructure assets for clients all over the globe. The stock is up by 44% since the start of the year.
The company could record further growth over the coming months after last quarter’s earnings result. The mergers and acquisitions by Brookfield have helped them accelerate growth in several areas.
In the third quarter of the year, the funds generated from operations were $338 million. This is higher than the $278 million recorded in the same quarter of last year. The most significant cash flow was generated from the data infrastructure segment. In this sector, Brookfield’s FFO roughly doubled from the same period in 2018.
JD.com Inc. (JD)
Chinese e-commerce giant, JD.com remains one of the most affordable growth stocks. The company’s stock has performed excellently in 2019, recently recording gains in the third quarter. JD.com’s stock is currently up by 47% year-to-date.
On November 18, JD.com reported better-than-expected third-quarter earnings. Sales of CN¥135b were 5% higher than analyst estimates. However, EPS missed expectations by 23%. JD.com’s stock has room for growth and it’s already up by 2% at Monday’s pre-market trading session.
Yandex N.V (YNDX)
Yandex is another growth stock that remains affordable after surging by 42% since the start of the year. The Russian internet and tech giant operates a popular search engine. The company is expected to make changes its corporate governance.
The changes could lead to further growth for the company over the coming months. The stock price remains affordable at its current price and could be set to record further growth in the future.
More Growth Stocks You Can Buy Cheap
Some growth stocks have experienced a surge in price since the start of the year. However, some of them remain very affordable. Stay tuned with the Dork and keep track of the best growth stocks to buy for cheap. You can also follow Stock Dork on Twitter and Facebook to track of all the latest stock market news. Also, don’t forget to sign up for mobile Dork Alerts to get all the hottest stock picks, insights, and analysis delivered to your cell.